Home / Health / FDA Chief Resigns Amidst Scrutiny
FDA Chief Resigns Amidst Scrutiny
12 May
Summary
- FDA Commissioner Marty Makary has stepped down from his role.
- Deputy Commissioner Kyle Diamantas will lead the agency temporarily.
- The transition occurs during a critical period for federal health policy.

FDA Commissioner Marty Makary has resigned, with Deputy Commissioner Kyle Diamantas appointed as the acting head of the agency. This leadership change is occurring at a critical time for federal health policy. The FDA has been under significant scrutiny regarding its decisions on drug approvals, vaccine oversight, and overall regulatory direction.
Diamantas currently serves as the deputy commissioner for human foods. In this role, he is responsible for nationwide food safety and nutrition policies. He also acts as a key liaison between the FDA, the Department of Health and Human Services, and the White House. His appointment as acting commissioner is expected to provide stability during the search for a permanent nominee.